Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
26.40
-0.16 (-0.62%)
Aug 19, 2026, 2:11 PM EDT - Market open

Pediatrix Medical Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9511,9142,0131,9951,9721,911
Revenue Growth
0.51%-4.92%0.92%1.15%3.18%10.22%
Gross Profit
511.77493.7454.34421.57467.03513.24
Operating Income
240.65231.09183.68157.85200217.74
Net Income
174.81165.39-99.07-60.4166.34130.96
Earnings Per Share
2.101.94-1.19-0.730.781.53
EPS Growth
62.19%----48.62%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
404.2499.72348.51177.74103.06487.11
Total Debt
619.96634.62662.31701.65717.081,066
Net Cash (Debt)
-215.76-134.89-313.81-523.91-614.02-578.72
Net Cash Growth
------
Net Cash Per Share
-2.58-1.58-3.77-6.37-7.30-6.74

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
246.86271.09206.57137.33166.9476.74
Capital Expenditures
-18.25-18.46-22.02-33.33-29.71-32.25
Free Cash Flow
228.61252.63184.55104137.2344.49
Free Cash Flow Growth
0.71%36.89%77.46%-24.22%208.47%-74.70%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.24%25.80%22.57%21.14%23.68%26.86%
Operating Margin
12.34%12.07%9.13%7.91%10.14%11.39%
Pretax Margin
11.60%11.31%-5.03%-2.42%4.13%7.08%
Profit Margin
8.96%8.64%-4.92%-3.03%3.36%6.85%
FCF Margin
11.72%13.20%9.17%5.21%6.96%2.33%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.3210.89--18.3517.71
Forward PE
11.019.928.867.408.2916.25
P/FCF Ratio
9.227.136.017.418.8752.14
PS Ratio
1.080.940.550.390.621.21